J.ophthalmol.(Ukraine).2021;4:43-47.

http://doi.org/10.31288/oftalmolzh202144347

Received: 28 December 2020; Published on-line: 16 August 2021


Longitudinal changes in the incidence of glaucoma in Uzbekistan

D. M. Tuychibayeva 1, Zh. A. Rizayev 2, N. K. Stozharova 1  

1 Tashkent State Dentistry Institute; Tashkent (Uzbekistan)

2 Samarkand State Medical Institute;Tashkent (Uzbekistan)

E-mail:  dyly@mail.ru

TO CITE THIS ARTICLE:Tuychibayeva D.M., Rizayev Zh.A., Stozharova N.K.  Longitudinal changes in the incidence of glaucoma in Uzbekistan  http://doi.org/10.31288/oftalmolzh202144347


Background: Glaucoma is not only one of the most common, but also one of the most severe chronic and progressive eye diseases. Therefore, the disease is a relevant problem in ophthalmology and a leading cause of reduced vision and irreversible blindness.

Purpose: To assess the incidence of glaucoma in the republic and the city of Tashkent, and predict disease incidence for the subsequent decade.

Material and Methods: The report of the Ministry of Health “On the numbers of diseases and registered patients residing in the primary service area of the medical facility» and national statistical collections (“Statistical materials on the activities of healthcare institutions of the Republic of Uzbekistan”) for 2010-2019 were studied to determine the incidence of glaucoma and the relevant characteristics in the republic.

Results: These materials allowed us to obtain the data on annual incidences of newly diagnosed cases and annual incidences of first visits of previously diagnosed cases of glaucoma in adults (i.e., individuals older than age 19) in the regions of the country for 2010 to 2019 years. The prediction of the incidence of glaucoma in the republic of Uzbekistan and the city of Tashkent necessitates organizational and treatment-and-diagnostic measures for combating the disease, these measures being of a social and medical importance.

Keywords: glaucoma, annual incidences of newly diagnosed cases and first visits of previously diagnosed cases, Uzbekistan, Tashkent

 

References

1.Avdeev RV, Alexandrov AS, Bakunina NA, Basinsky AS, Blum EA., Brezhnev AYu, et al. [Prediction of disease duration and age of patients with different stages of primary open-angle glaucoma]. Natsionalnyi zhurnal glaucoma. 2014; 13(2):60-69. Rus-sian. https://doi.org/10.25700/NJG.2019.01.07.

2.Egorov EA, Kuroedov AV. [Clinical and epidemiological characteristics of glaucoma in CIS and Georgia. Results of multicenter opened retrospective trial (part 1)]. Rossiiskii Meditsinskii zhurnal. Klinicheskaia Oftalmologiia. 2011; 12(3):97-100. Russian.

3.Egorov EA, Astakhov YuS, Erichev VP, editors. [National Guidelines for Glaucoma For Medical Practitioners]. 3rd ed., rev. and enlarged. Moscow: GEOTAR-Media; 2015. Russian. 

4.Egorov EA, Astakhov YuS, Erichev VP, editors. [National Guidelines for Glaucoma For Medical Practitioners]. 4th ed., rev. and enlarged. Moscow: GEOTAR-Media; 2019. Russian. DOI: 10.33029/9704-5442-8-GLA-2020-1-384.

Crossref 

5.Neroev VV, Kiseleva OA, Bessmertny AM. [The main results of a multicenter study of the epidemiological features of primary open-angle glaucoma in the Russian Federation]. Rossiiskii oftal’mologicheskii zhurnal. 2013;6 (3):43–46. Russian. Available from:   https://roj.igb.ru/jour/manager/files/archive//РОЖ_3_2013.pdf.

6.Libman YeS, Kaleyeva EV, Ryazanov DP. [Characteristics of visual disability in the Russian Federation]. Rossiiskaia oftal'mologi-ia. 2012; 5:24-26. Russian. Available from:  https://eyepress.ru/article.aspx?8868

7.Babushkin AE, Orenburkina OI, Matyukhina EN, et al. [Analysis of the prevalence and incidence of and disability due to glaucoma in the Republic of Bashkortostan]. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2011; 14: 45–48. Russian.   https://doi.org/10.25198/1814-6457

Crossref

8.Baranov VI, Brezhnev AYu, Tolmacheva EM. [Social and economical and epidemiological aspects of glaucoma in Kursk region]. In: [Eliminating Avoidable Blindness: A WHO World Initiative. Elimination of Childhood Blindness: Proceedings of the 6th Russian Interregional Symposium]. Moscow. 2012:46-48. Russian.

9.Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006 Mar; 90(3):262–7.

Crossref

10.Nesterov AP. [Glaucoma]. Moscow:Medinformagenstvo; 2008. Russian. 

11.Sharaf VM, Siplivyi VI. [Epidemiological features of the clinical course of glaucoma depending on social, economical, ethnic and geographical factors]. Natsionalnyi zhurnal glaucoma. 2014;13(1):68-76. Russian. Available from: https://www.glaucomajournal.ru/jour/article/view/10/11 

12.Rosman M, Zheng Y, Lamoureux E, et al. Review of key findings from the Singapore Malay Eye Study (SiMES-1). Singapore Medical Journal. – 2012; 53(2):82-7.

13.Al-Bahlal A, Khandekar R, Al Rubaie K, et al. Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia. Indian J Ophthalmol. 2017 Oct;65(10):969-973.  doi: 10.4103/ijo.IJO_33_17. 

Crossref

14.Islam FM, Chakrabarti R, Islam SZ, et al. Factors associated with awareness, attitudes and practices regarding common eye diseases in the general population in a rural district in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES) PLOS One. 2015;10:e0133043. 

Crossref 

15.Katibeh M, Ziaei H, Panah E, et al. Knowledge and awareness of age related eye diseases: a population-based survey. J Ophthalmic Vis Res. 2014 Apr; 9(2): 223–31. 

16.Ryskulova A, Turczyn K, Makuc DM, et al. Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 National Health Interview Study. Am J Pub Health. 2008;98:454–61. 

Crossref

17.Rizayev JA, Tuychibayeva DM. Prediction of glaucoma frequency and prevalence in Uzbekistan. Journal of Biomedicine and Practice. 2020; 6(5): 180-6. http://doi.org/10.26739/2181-9300-2020-6-28.

18.Akhmedov D, Kucera T. Uzbekistan Population Forecast 2018-50. UNFPA in Uzbekistan:Prague-Tashkent; 2019.

Conflict of Interest Statement:

No conflict of interest to declare.